President & CEO

Cary Hagan joined Intrinsic in 2011 from Wright Medical, where he served as Senior Vice President, Commercial Operations, for Europe, Middle East and Africa. He began his career at Wright Medical in 1989 and advanced through a series of Sales and Marketing positions with increasing responsibility. As Senior Director of Biologics, Cary was pivotal in the rapid growth of Wrights Orthobiologics program from “point zero” to market segment leader. Later as Vice President Marketing, Global OrthoRecon, he oversaw a turnaround in Wright’s Hip and Knee growth rates to roughly two times the industry average.

Cary completed undergraduate at Westminster College in Fulton, Missouri, with majors in both Business Administration & Economics. He later earned a Master’s in Business Administration at St. Louis University & Webster Universities, with a focus on International Business.


Founder & Executive Director

Prior to founding Intrinsic in 1999, Greg Lambrecht was a Vice President of Product Development & Marketing at Stryker, a global orthopedic implant company, where he directed the development and launch of numerous successful orthopedic implants. Greg also held various management positions in product and business development within Pfizer’s Medical Technology Group. The core of his career at Pfizer was implementing a process for inventing and developing new technologies that best met the needs of Pfizer’s physician customers worldwide.

Greg received a Bachelor of Science in Nuclear Engineering from the Massachusetts Institute of Technology in 1990 and returned to the same institution for a Masters Degree in Mechanical Engineering in 1993. Greg holds numerous patents in the fields of gynecology, general surgery, cardiology, and orthopedics.



Chief Technology Officer

Prior to joining Intrinsic in 2000, Jacob Einhorn was Director of Product Development for Nippon Stryker, the Japanese operating division of Stryker Corporation, a global medical device company focused on the orthopedic market, where Jacob was responsible for establishing Stryker’s first R&D presence in Asia.

Jacob received a Bachelor of Arts in Physics and Anthropology from the Johns Hopkins University in 1992. Following several years of consumer products research and consumer advocacy in Washington, DC, he received a Masters of Science in Mechanical Engineering from MIT in 1997. Jacob holds numerous patents in the field of orthopedics and is an active mentor of budding med-tech entrepreneurs.


Vice President, Sales

Robert Spomer joined Intrinsic as the Vice President of Sales in August of 2022. Prior to joining Intrinsic, Robert served as a Western Area Sales Director for the Interventional Urology Division of Teleflex. Robert has successfully sold for and led teams at multiple disruptive technologies companies including: Stryker, Acclarent (acquired by JNJ), Spirox (acquired by Entellus), and Neotract (acquired by Teleflex). By serving in multiple sales leadership and marketing roles, Robert has had the opportunity to help lead teams that have successfully launched many first to market technologies in both the United States and Europe. 

Mr. Spomer holds a Bachelor of Science in Business Administration from Regis University in Denver, Colorado. He also holds a Masters of Business Administration from The Kelley School of Business at Indiana University. 



Chief Operating Officer

Oscar Yeh joined Intrinsic in 2004 and was initially responsible for the pre-clinical evaluation of the Barricaid in benchtop, cadaveric, and animal testing. He has held multiple leadership roles within Intrinsic and is currently responsible for research efforts stemming from the clinical and radiographic data collected in the Barricaid randomized clinical trial.

Oscar joined Intrinsic from the University of California, Davis Medical Center where he collaborated on basic science research projects within the Orthopaedic Surgery department. Research efforts included the response of musculoskeletal tissues to mechanical loading through the use of animal models, biomechanical testing, histology, finite element analysis, and constitutive modeling.

Peter Pizzo

Chief Financial Officer

Peter Pizzo joined Intrinsic as its Chief Financial Officer in August 2022. Prior to joining the company, he served as Chief Financial Officer of several private medical device companies, including ControlRad, Inc., Cartiva, Inc., which was sold to Wright Medical for $435 million, and Proxima Therapeutics, Inc., which was sold to Cytyc Corporation for $190 million. From 1996 to 2001, Mr. Pizzo worked for Serologicals Corporation, a publicly traded provider of biological products to life science companies, ultimately serving as Chief Financial Officer. Peter previously served as Vice President and Controller of ValueMark Healthcare Systems, Inc., a privately held owner-operator of psychiatric hospitals and in various senior financial positions at Hallmark Healthcare Corporation, a publicly traded hospital company.

Since 2010, Peter has served on the board of directors of Alimera Sciences, Inc. (Nasdaq: ALIM), a publicly traded global pharmaceutical company, where he chairs the Audit Committee and is a member of the Compensation Committee.

Peter earned his bachelor’s degree in business administration/accounting from Washington and Lee University in Lexington, Virginia.



Vice President Clinical Affairs

Kelsey Miller-Torchia joined Intrinsic in 2011 from Impliant, where she served as their Marketing Manager overseeing their US IDE, and clinical trials in Brazil, Israel and Belgium. Kelsey brings with her over 17 years of global clinical trial experience in the spinal industry. 

Kelsey started her career in academics with The Boston Spine Group at the renowned New England Baptist Hospital. There she developed and managed their patient registries as well as managed their investigator and IDE clinical trials.  Kelsey has a BA in South East Asian Studies and Religion from Tufts University.


Vice President, Customer Relations and Sales Operations

Ralph Beentjes joined Intrinsic from MicroPort Orthopedics, where he served as Sr. Director of Operations, with responsibility for Logistics & Customer Service, Global Integrated Business Planning and Product Lifecycle Management.  Ralph brings over 13 years of Sales Operations and Customer Relations experience in the medical device industry.

As Vice President of Customer Relations and Sales Operations he manages all aspects of commercialization support, customer targeting and monitoring, utilizing current technology that interfaces with Sales Management and across the business.  

Ralph holds a Masters of Science with merit from Tias Nimbas Business School – Bradford University, with a focus on International Business and Marketing.


Vice President, Marketing

Jake Tanner joined Intrinsic following the successful launch of five startup companies related to trauma/burn care, healthcare finance, Ambulatory Surgery Center creation and management, corporate wellness, and internet marketing.

His most recent experience comes from PolyNovo, where as the Director of Marketing he and his team successfully launched a revolutionary trauma and burn care product into a crowded market. While in this role, PolyNovo expanded geographically from 3 to 30+ Sales territories and implemented strategies that resulted in a 15X increase in revenue.  He also held Product Management and Marketing positions with ATEC Spine and NuVasive where he developed an excellent track record for all aspects of the positions including the development of marketing strategies, product launches, KOL development and management, training, contracting, etc.

Jake holds a Bachelor of Science with an emphasis on Entrepreneurship from the Marriott School of Business at Brigham Young University.




If Barricaid is right for you, we can help.

Sign up to receive future updates and information on the Barricaid procedure.
  • This field is for validation purposes and should be left unchanged.

WordPress Lightbox Plugin